Table 5 Summary of hemostasis, admission and re-presentation rates comparing treatment (Floseal® (Baxter, USA)) to control (traditional packing methods)
Treatment (Floseal) (N = 13) | Control (N = 13) | p-valuea | |
|---|---|---|---|
Hemostasis Post-Treatment | 10 (76.9%) | 11 (84.6%) | 1.0000 |
Hemostasis at 48-h | 10 (76.9%) | 9 (69.2%) | 1.0000 |
Admission Required | 2 (15.4%) | 6 (46.1%) | 0.2016 |
30 Day ED Re-Presentation | 2 (15.4%) | 6 (46.1%) | 0.2016 |
Adverse Events | 0 (0.0%) | 0 (0.0%) | 1.0000 |